{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:16:02Z","timestamp":1792016162604,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012182","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000}}],"reference-count":151,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012182.pub2","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T16:48:15Z","timestamp":1520441295000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":227,"title":["Cannabis-based medicines for chronic neuropathic pain in adults"],"prefix":"10.1002","volume":"2020","author":[{"given":"Martin","family":"M\u00fccke","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine; University Hospital of Bonn; Bonn Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tudor","family":"Phillips","sequence":"additional","affiliation":[{"name":"Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Radbruch","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine; University Hospital of Bonn; Bonn Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Petzke","sequence":"additional","affiliation":[{"name":"Pain Clinic; Universit\u00e4tsmedizin G\u00f6ttingen; G\u00f6ttingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"H\u00e4user","sequence":"additional","affiliation":[{"name":"Department of Psychosomatic Medicine and Psychotherapy; Technische Universit\u00e4t M\u00fcnchen; M\u00fcnchen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"key":"10.1002\/14651858.CD012182.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.pain.2004.09.013","article-title":"Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial","volume":"112","author":"Berman","year":"2004","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD012182.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/npp.2008.120","article-title":"Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial","volume":"34","author":"Ellis","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.39429.619653.80","article-title":"Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study","volume":"336","author":"Frank","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s00415-012-6739-4","article-title":"A double-blind, randomized, placebo-controlled, parallel-group study of THC\/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis","volume":"260","author":"Langford","year":"2013","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpainsymman.2013.02.018","article-title":"A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain","volume":"47","author":"Lynch","year":"2014","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0006|cit6","unstructured":"A study of Sativex\u00ae for pain relief due to diabetic neuropathy clinicaltrials.gov\/ct2\/results?term=NCT00710424+&Search=Search"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0007|cit7","unstructured":"A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin clinicaltrials.gov\/ct2\/results?cond=&term=NCT01606176&cntry1=&state1=&recrs="},{"key":"10.1002\/14651858.CD012182.pub2-BIB0008|cit8","unstructured":"A study of cannabis based medicine extracts and placebo in patients with pain due to spinal cord injury clinicaltrials.gov\/ct2\/results?term= NCT 01606202&Search=Search"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pain.2007.08.028","article-title":"Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial","volume":"133","author":"Nurmikko","year":"2007","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000176753.45410.8b","article-title":"Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis","volume":"65","author":"Rog","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000481089","article-title":"Dronabinol is a safe long-term treatment option for neuropathic pain patients","volume":"78","author":"Schimrigk","year":"2017","journal-title":"European Neurology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2337\/dc09-1029","article-title":"Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy: depression is a major confounding factor","volume":"33","author":"Selvarajah","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/j.1532-2149.2013.00445.x","article-title":"A double-blind, randomized, placebo-controlled, parallel group study of THC\/CBD spray in peripheral neuropathic pain treatment","volume":"18","author":"Serpell","year":"2014","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.38149.566979.AE","article-title":"Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial","volume":"329","author":"Svendsen","year":"2004","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.pain.2012.06.024","article-title":"An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain","volume":"153","author":"Toth","year":"2012","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"E694","DOI":"10.1503\/cmaj.091414","article-title":"Smoked cannabis for chronic neuropathic pain: a randomized controlled trial","volume":"184","author":"Ware","year":"2010","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1212\/01.wnl.0000253187.66183.9c","article-title":"Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial","volume":"68","author":"Abrams","year":"2007","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1503\/cmaj.110837","article-title":"Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial","volume":"184","author":"Corey-Bloom","year":"2012","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.290.13.1757","article-title":"Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial","volume":"290","author":"Karst","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2044.2004.03674.x","article-title":"Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 'N of 1' studies","volume":"59","author":"Notcutt","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1468-1331.2010.03328.x","article-title":"Arandomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(\u00ae)), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis","volume":"18","author":"Novotna","year":"2011","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/PHM.0b013e3181f1c4ec","article-title":"Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study","volume":"89","author":"Rintala","year":"2010","journal-title":"American Journal of Physical Medicine & Rehabilitation"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/pme.12569","article-title":"Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: a randomized controlled trial","volume":"16","author":"Turcotte","year":"2015","journal-title":"Pain Medicine"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1191\/0269215503cr581oa","article-title":"A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms","volume":"17","author":"Wade","year":"2003","journal-title":"Clinical Rehabilitation"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","article-title":"Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients","volume":"10","author":"Wade","year":"2004","journal-title":"Multiple Sclerosis"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jpain.2015.03.008","article-title":"Efficacy of inhaled cannabis on painful diabetic neuropathy","volume":"16","author":"Wallace","year":"2015","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jpain.2007.12.010","article-title":"A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain","volume":"9","author":"Wilsey","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jpain.2012.10.009","article-title":"Low-dose vaporized cannabis significantly improves neuropathic pain","volume":"14","author":"Wilsey","year":"2013","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00415-006-0218-8","article-title":"Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain: a double-blind placebo-controlled cross-over trial","volume":"253","author":"Wissel","year":"2006","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(03)14738-1","article-title":"Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomized placebo-controlled trial","volume":"362","author":"Zajicek","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/jnnp-2012-302468","article-title":"Multiple sclerosis and extract of cannabis: results of the MUSEC trial","volume":"83","author":"Zajicek","year":"2012","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0032|cit32","unstructured":"Nabilone for the treatment of phantom limb pain clinicaltrials.gov\/ct2\/show\/NCT00699634?term=NCT00699634&rank=1"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0033|cit33","unstructured":"Efficacy study of nabilone in the treatment of diabetic peripheral neuropathic pain clinicaltrials.gov\/ct2\/show\/NCT01035281?term=NCT01035281&rank=1"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0034|cit34","unstructured":"Effect of cannabinoids on spasticity and neuropathic pain in spinal cord injured persons clinicaltrials.gov\/ct2\/show\/NCT01222468?term=NCT01222468&rank=1"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00482-015-0083-4","article-title":"Medical use of cannabis products: lessons to be learned from Israel and Canada","volume":"30","author":"Ablin","year":"2016","journal-title":"Schmerz"},{"issue":"2","key":"10.1002\/14651858.CD012182.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.ijcard.2012.11.048","article-title":"Random error in cardiovascular meta-analyses: how common are false positive and false negative results?","volume":"168","author":"AlBalawi","year":"2013","journal-title":"Interational Journal of Cardiology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0037|cit37","first-page":"1134","article-title":"Pharmacoepidemiological research with large health databases","volume":"51","author":"Andersohn","year":"2008","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"12","key":"10.1002\/14651858.CD012182.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jpain.2015.07.009","article-title":"Inhaled cannabis for chronic neuropathic pain: a meta-analysis of individual patient data","volume":"16","author":"Andreae","year":"2015","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1474-4422(16)00017-X","article-title":"Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial","volume":"15","author":"Attal","year":"2016","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00132-004-0645-0","article-title":"How neuropathic is sciatica? The mixed pain concept","volume":"33","author":"Baron","year":"2004","journal-title":"Orthop\u00e4de"},{"issue":"1","key":"10.1002\/14651858.CD012182.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1474-4422(11)70281-","article-title":"Chronic pain: genes, plasticity, and phenotypes","volume":"11","author":"Baron","year":"2012","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/j.pain.0000000000000753","article-title":"Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles","volume":"158","author":"Baron","year":"2017","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD012182.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jpain.2003.12.004","article-title":"Clinical characteristics and economic costs of patients with painful neuropathic disorders","volume":"5","author":"Berger","year":"2004","journal-title":"Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD012182.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1533-2500.2008.00244.x","article-title":"Clinical and economic characteristics of patients with painful neuropathic disorders in Germany","volume":"9","author":"Berger","year":"2009","journal-title":"Pain Practice"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2377-12-8","article-title":"Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study","volume":"12","author":"Berger","year":"2012","journal-title":"BMC Neurology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD012182.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.11607\/ofph.1274","article-title":"The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review","volume":"29","author":"Boychuk","year":"2015","journal-title":"Journal of Oral and Facial Pain and Headache"},{"issue":"7","key":"10.1002\/14651858.CD012182.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1474-4422(12)70134-5","article-title":"The role of the immune system in the generation of neuropathic pain","volume":"11","author":"Calvo","year":"2012","journal-title":"Lancet Neurology"},{"issue":"11","key":"10.1002\/14651858.CD012182.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1097\/j.pain.0000000000000311","article-title":"What is the meaning of \"small fiber neuropathy\" in fibromyalgia?","volume":"156","author":"Clauw","year":"2015","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0050|cit50","unstructured":"Palliative and Supportive Care Group PaPaS author and referee guidance papas.cochrane.org\/papas-documents"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0051|cit51","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1517\/14656566.2014.918102","article-title":"Dronabinol and chronic pain: importance of mechanistic considerations","volume":"15","author":"De Vries","year":"2014","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"f2304","DOI":"10.1136\/bmj.f2304","article-title":"Influence of trial sample size on treatment effect estimates: meta-epidemiological study","volume":"346","author":"Dechartres","year":"2013","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jama.2014.8166","article-title":"Association between analytic strategy and estimates of treatment outcomes in meta-analyses","volume":"312","author":"Dechartres","year":"2014","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD012182.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.pain.2014.08.014","article-title":"The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study","volume":"155","author":"Demant","year":"2014","journal-title":"Pain"},{"issue":"9","key":"10.1002\/14651858.CD012182.pub2-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010111","article-title":"Topical capsaicin (low concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012182.pub2-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010958.pub2","article-title":"Topical lidocaine for neuropathic pain in adults","author":"Derry","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012182.pub2-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007393.pub4","article-title":"Topical capsaicin (high concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012182.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.pain.2013.06.004","article-title":"Interventional management of neuropathic pain: NeuPSIG recommendations","volume":"154","author":"Dworkin","year":"2013","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD012182.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0062|cit62","unstructured":"Guideline on clinical medicinal products intended for the treatment of neuropathic pain www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003478.pdf"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11136-013-0443-4","article-title":"Don't middle your MIDs: regression to the mean shrinks estimates of minimally important differences","volume":"23","author":"Fayers","year":"2014","journal-title":"Quality of Life Research"},{"issue":"7","key":"10.1002\/14651858.CD012182.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/j.1532-2149.2012.00282.x","article-title":"Neuropathic pain needs systematic classification","volume":"17","author":"Finnerup","year":"2013","journal-title":"European Journal of Pain"},{"issue":"2","key":"10.1002\/14651858.CD012182.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.22267","article-title":"The dilemma of medical marijuana use by rheumatology patients","volume":"66","author":"Fitzcharles","year":"2014","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004850-200501000-00010","article-title":"Imputing response rates from means and standard deviations in meta-analyses","volume":"20","author":"Furukawa","year":"2005","journal-title":"International Clinical Psychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD012182.pub2-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010692.pub3","article-title":"Oxycodone for neuropathic pain in adults","author":"Gaskell","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0069|cit69","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/187152709789824660","article-title":"The endocannabinoid system and pain","volume":"8","author":"Guindon","year":"2009","journal-title":"CNS & Neurological Disorders Drug Targets"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1399-6576.2007.01486.x","article-title":"Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey","volume":"52","author":"Gustorff","year":"2008","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2296-9-26","article-title":"Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005","volume":"9","author":"Hall","year":"2008","journal-title":"BMC Family Practice"},{"issue":"2","key":"10.1002\/14651858.CD012182.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/cpt.19","article-title":"Individualized pharmacological treatment of neuropathic pain","volume":"97","author":"Helfert","year":"2015","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0077|cit77","unstructured":"Higgins JPT Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0078|cit78","unstructured":"Higgins JPT Deeks JJ Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroscience.2011.11.020","article-title":"Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence","volume":"204","author":"Hillard","year":"2012","journal-title":"Neuroscience"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00415-014-7502-9","article-title":"A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC\/CBD oromucosal spray in the management of neuropathic pain","volume":"262","author":"Hoggart","year":"2015","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/AJP.0b013e3182321ad8","article-title":"Adverse events attributable to nocebo in randomized controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy: systematic review","volume":"28","author":"H\u00e4user","year":"2012","journal-title":"Clinical Journal of Pain"},{"issue":"7","key":"10.1002\/14651858.CD012182.pub2-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011694","article-title":"Cannabinoids for fibromyalgia","author":"Walitt","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0083|cit83","first-page":"627","article-title":"Efficacy, tolerability and safety of cannabinoids in pain medicine and palliative care: an overview of systematic reviews and of prospective observational studies","volume":"114","author":"H\u00e4user","year":"2017","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0084|cit84","doi-asserted-by":"crossref","unstructured":"H\u00e4user W Petzke F Fitzcharles MA Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - an overview of systematic reviews European Journal of Pain 2018 22 455 70","DOI":"10.1002\/ejp.1118"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0085|cit85","unstructured":"International Council for Harmonisation Medical Dictionary for Regulatory Activities Version 19.1 www.meddra.org\/news-and-events\/news\/all-translations-meddra-version-191-are-now-available 2016"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0086|cit86","doi-asserted-by":"crossref","unstructured":"Jensen TS Baron R Haanp\u00e4\u00e4 M Kalso E Loeser JD Rice AS A new definition of neuropathic pain Pain 2011 152 10 2204 5 10.1016\/j.pain.2011.06.017","DOI":"10.1016\/j.pain.2011.06.017"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s11916-015-0524-x","article-title":"Medical marijuana and chronic pain: a review of basic science and clinical evidence","volume":"19","author":"Jensen","year":"2015","journal-title":"Current Pain Headache Reports"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1155\/2001\/469629","article-title":"Medicinal use of cannabis: history and current status","volume":"6","author":"Kalant","year":"2001","journal-title":"Pain Research & Management"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"f7339","DOI":"10.1136\/bmj.f7339","article-title":"Drugs for neuropathic pain","volume":"347","author":"Kalso","year":"2013","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000110284","article-title":"Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota,1945-1984","volume":"10","author":"Katusic","year":"1991","journal-title":"Neuroepidemiology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pain.2009.08.023","article-title":"Incidence of facial pain in the general population","volume":"147","author":"Koopman","year":"2009","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1212\/WNL.0000000000000363","article-title":"Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"82","author":"Koppel","year":"2014","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0093|cit93","doi-asserted-by":"crossref","unstructured":"Krcevski-Skvarc N Wells C H\u00e4user W Availability and approval of cannabis- based medicines for chronic pain management and palliative\/supportive care in Europe - a survey of the status in the chapters of the European Pain Federation European Journal Pain 2018 22 440 54","DOI":"10.1002\/ejp.1147"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0095|cit95","first-page":"123","article-title":"Amygdala activity contributes to the dissociative effect of cannabis on pain perception","volume":"134","author":"Lee","year":"2013","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"20,270","DOI":"10.1073\/pnas.0909411106","article-title":"Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo","volume":"106","author":"Long","year":"2009","journal-title":"Proceedings of the National Academy of Science of the United States of America"},{"issue":"1","key":"10.1002\/14651858.CD012182.pub2-BIB0097|cit97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub3","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","author":"Lunn","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2125.2011.03970.x","article-title":"Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials","volume":"72","author":"Lynch","year":"2011","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0099|cit99","volume-title":"An Evidence-Based Resource for Pain Relief","author":"McQuay","year":"1998"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0100|cit100","volume-title":"In: Stevens A, Raftery J, Mant J, Simpson S, editor(s). Health Care Needs Assessment, 3rd Series","author":"McQuay","year":"2007"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0101|cit101","first-page":"43","article-title":"Clinical trial transparency: many gains but access to evidence for new medicines remains imperfect","volume":"116","author":"Mintzes","year":"2015","journal-title":"British Medical Bulletin"},{"issue":"7","key":"10.1002\/14651858.CD012182.pub2-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012182.pub2-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0104|cit104","first-page":"15","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD012182.pub2-BIB0105|cit105","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012182.pub2-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012182.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012182.pub2-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD012182.pub2-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pain.2010.07.013","article-title":"Numbers-needed-to-treat analyses - do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD012182.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD012182.pub2-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"2","key":"10.1002\/14651858.CD012182.pub2-BIB0112|cit112","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anesthesia"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012182.pub2-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"issue":"1","key":"10.1002\/14651858.CD012182.pub2-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/j.1532-2149.2013.00341.x","article-title":"Duloxetine use in chronic painful conditions - individual patient data responder analysis","volume":"18","author":"Moore","year":"2014","journal-title":"European Journal of Pain"},{"issue":"10","key":"10.1002\/14651858.CD012182.pub2-BIB0117|cit117","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010902.pub2","article-title":"Oral nonsteroidal anti-inflammatory drugs for neuropathic pain","author":"Moore","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012182.pub2-BIB0118|cit118","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008242.pub3","article-title":"Amitriptyline for neuropathic pain in adults","author":"Moore","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012182.pub2-BIB0119|cit119","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub4","article-title":"Gabapentin for chronic neuropathic pain in adults","author":"Wiffen","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1155\/2014\/754693","article-title":"Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society","volume":"19","author":"Moulin","year":"2014","journal-title":"Pain Research & Management"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0121|cit121","unstructured":"National Institute for Health and Care Excellence (NICE) Neuropathic pain - pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialist settings, 2013 www.nice.org.uk\/guidance\/cg173"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"c3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/525S6a","article-title":"Drug development: the treasure chest","volume":"525","author":"Owens","year":"2015","journal-title":"Nature"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00482-015-0089-y","article-title":"Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: a systematic review of randomized controlled studies","volume":"30","author":"Petzke","year":"2016","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0304-3959(94)90086-8","article-title":"Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion","volume":"56","author":"Rappaport","year":"1994","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0126|cit126","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00482-014-1451-1","article-title":"Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration","volume":"29","author":"Schaefert","year":"2015","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0128|cit128","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"issue":"9","key":"10.1002\/14651858.CD012182.pub2-BIB0129|cit129","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.vaccine.2005.09.026","article-title":"The burden of herpes zoster: a prospective population based study","volume":"24","author":"Scott","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1002\/14651858.CD012182.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/j.pain.0000000000000502","article-title":"Pain intensity rating training: results from an exploratory study of the ACTTION PROTECCT system","volume":"157","author":"Smith","year":"2016","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00482-014-1455-x","article-title":"Opioids in chronic neuropathic pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration","volume":"29","author":"Sommer","year":"2015","journal-title":"Schmerz"},{"issue":"5","key":"10.1002\/14651858.CD012182.pub2-BIB0132|cit132","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011604.pub2","article-title":"Hydromorphone for neuropathic pain in adults","author":"Stannard","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012182.pub2-BIB0133|cit133","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200.","article-title":"Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia - responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0135|cit135","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"issue":"10","key":"10.1002\/14651858.CD012182.pub2-BIB0136|cit136","doi-asserted-by":"publisher","first-page":"e25491","DOI":"10.1371\/journal.pone.0025491","article-title":"The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study","volume":"6","author":"Thorlund","year":"2011","journal-title":"PLOS One"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/0269215513514231","article-title":"How to measure pain in neurological conditions? A systematic review of psychometric properties and clinical utility of measurement tools","volume":"28","author":"Tyson","year":"2014","journal-title":"Clinical Rehabilitation"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jpain.2005.11.008","article-title":"The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey","volume":"7","author":"Torrance","year":"2006","journal-title":"Journal of Pain"},{"issue":"18","key":"10.1002\/14651858.CD012182.pub2-BIB0139|cit139","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD012182.pub2-BIB0140|cit140","doi-asserted-by":"publisher","first-page":"e59202","DOI":"10.1371\/journal.pone.0059202","article-title":"The impact of study size on meta-analyses: examination of underpowered studies in Cochrane Reviews","volume":"8","author":"Turner","year":"2013","journal-title":"PLOS One"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"Van Hecke","year":"2014","journal-title":"Pain"},{"issue":"9","key":"10.1002\/14651858.CD012182.pub2-BIB0142|cit142","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.vaccine.2008.12.024","article-title":"Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales","volume":"27","author":"Van Hoek","year":"2009","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use","volume":"370","author":"Volkow","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012182.pub2-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.neuron.2012.02.008","article-title":"Deconstructing the neuropathic pain phenotype\u00a0to reveal neural mechanisms","volume":"73","author":"Hehn","year":"2012","journal-title":"Neuron"},{"issue":"9859","key":"10.1002\/14651858.CD012182.pub2-BIB0145|cit145","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jpain.2015.07.014","article-title":"Cannabis for the management of pain: assessment of safety study (COMPASS)","volume":"16","author":"Ware","year":"2015","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD012182.pub2-BIB0148|cit148","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010567.pub2","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1756285615612659","article-title":"Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis","volume":"9","author":"Zettl","year":"2016","journal-title":"Therapeutic Advances in Neurological Disorders"},{"key":"10.1002\/14651858.CD012182.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2174\/1381612820666141027115508","article-title":"Can modulating inflammatory response be a good strategy to treat neuropathic pain?","volume":"21","author":"Zhang","year":"2015","journal-title":"Current Pharmaceutical Design"},{"issue":"5","key":"10.1002\/14651858.CD012182.pub2-BIB0151|cit151","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012182","article-title":"Cannabinoids for chronic neuropathic pain","author":"M\u00fccke","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd012182.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD012182.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T23:03:47Z","timestamp":1628550227000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012182.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,7]]},"references-count":151,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012182.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,7]]}}}